Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HC-1119 in Hospitalized COVID-19 Patients
NCT04986176Phase 3Unknown
- Start
- Apr 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of deutenzalutamide in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
deutenzalutamide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04986176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04986176.